We aim to minimise any disruptions to industrial chemical importers and manufacturers as we move from NICNAS to AICIS.
We'll also publish more guidance as we head towards the new scheme.
Part 11 of the Transitional Rules has more details about moving to the Inventory under the new law. You should read Part 11 of the Transitional Rules in conjunction with Part 5, Schedule 2 of the CATP Act.
Transition of industrial chemicals listed on the NICNAS public inventory
We'll migrate all chemicals that have an industrial use to the new Inventory.
The Australian Inventory of Chemical Substances will become the Australian Inventory of Industrial Chemicals. We will continue to call it the Inventory. Chemicals that have never had an industrial use will not be included in the new Inventory.
Transition of industrial chemicals listed on the NICNAS confidential inventory
Current arrangements for protecting confidentiality will continue. We'll migrate them to the new Inventory.
They will not be searchable on the new AICIS website and we won't publish any details about these confidentially listed chemicals. Like now, anyone with a genuine intent to import or manufacture the chemical can make a request via our Business Services site to search for chemicals on the Inventory that have been confidentially listed.
After you submit a request we will:
- check to see if the chemical is listed confidentially on the Inventory
- confirm whether the chemical is available for import or manufacture in Australia
- check to see if your planned use of the chemical complies with any conditions/terms of listing
How will conditions of use on the current Inventory be treated in the new Inventory?
They'll become either a 'defined scope of assessment' or a 'condition of introduction or use'.
This infographic provides a quick overview of the introduction process under AICIS.
Some chemicals on the NICNAS Inventory have a condition of use associated with that chemical. These conditions of use will become either a defined scope of assessment or a condition of introduction or use on the AICIS Inventory.
What is a defined scope of assessment under AICIS?
A defined scope of assessment describes the parameters of any previous assessment of a chemical. You must check whether your planned importation or manufacture (introduction) falls within a defined scope of assessment. If your planned introduction is not within a defined scope of assessment on the chemical’s Inventory listing, then it can't be categorised as a listed introduction. You'll have to categorise your introduction under one of the other introduction categories:
- Assessed — because it's already on the Inventory, you'll need to apply to vary the terms of an Inventory listing
- Commercial evaluation authorisation
- Exceptional circumstances authorisation
What is a condition of introduction or use under AICIS?
A condition of introduction or use can include how much (annual volume) you can import or manufacture and restrictions on where the chemical can be used. You must check whether your planned introduction falls within any conditions of introduction or use. If your planned introduction does not fall within a condition of introduction or use on the chemical's Inventory listing, then it can't be categorised as a listed introduction.
Before you introduce the chemical, you must apply to AICIS for a variation of the Inventory listing. Your introduction is not authorised until AICIS approves the variation.
The transition of chemicals with NICNAS conditions of use to AICIS
The tables below list chemicals with conditions of use under NICNAS and whether those conditions will become defined scope of assessment or condition of introduction or use.Expand All
Chemicals that will become defined scope of assessment under AICIS
Chemicals with NICNAS conditions of use that will become defined scope of assessment under AICIS
|Item||Chemical name||CAS no.|
|1||Hexanoic acid, 2-ethyl-, 1,1’-(2,2-dimethyl-1,3-propanediyl) ester||28510-23-8|
|2||1H-Indole-5,6-diol, 2,3-dihydro-, hydrobromide (1:1)||138937-28-7|
|3||Castor oil, monomaleate||241153-84-4|
|4||Pyridine, 4-ethenyl-, reaction products with 3a, 4, 7, 7a-tetrahydrodimethyl-4, 7-methano-1 H–indene||125352-06-9|
|5||Nitriles, tallow, hydrogenated, reaction products with acrylonitrile, hydrogenated, reaction products with propylene oxide||490021-69-7|
|7||L-Ascorbic acid, 2-(3-aminopropyl hydrogen phosphate)||220644-17-7|
|8||L-Arginine, 3-(4-hydroxy-3-methoxyphenyl)-2-propenoate (1:1)||950890-74-1|
|9||L-Ascorbic acid, tetrakis(2-hexyldecanoate)||183476-82-6|
|10||L-Ascorbic acid, 2-[(2R)-3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-yl (2Z)-2-butenedioate], compd. with 1-propanol (1:1)||488109-67-7|
|11||Benzenesulfonic acid, 4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]-||56039-58-8|
|12||Decanoic acid, mixed diesters with 1,2-butanediol and octanoic acid||686341-29-7|
|13||Fatty acids, C10-30, esters with lanolin alcs.||97862-72-1|
|14||9,12-Octadecadienoic acid (9Z,12Z)-, 30-[[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]amino]-30-oxotriacontyl ester||156170-27-3|
|17||Propanamide, 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]-, hydrochloride (1:2)||57022-38-5|
|18||α-D-Glucopyranosiduronic acid, (3β,20β)-20-carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-β-D-glucopyranuronosyl-, potassium salt (1:2)||68797-35-3|
|19||1H-Benzimidazole-4,6-disulfonic acid, 2,2’-(1,4-phenylene)bis-, disodium salt||180898-37-7|
|20||Quaternary ammonium compounds, di-C16-18-alkyldimethyl, salts with hectorite||94891-31-3|
|23||2-Propenoic acid, homopolymer, ester with 1,2,3-propanetriol||104365-75-5|
|24||Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, ether with methyl β-d-glucopyranoside (4:1)||68239-42-9|
|27||1,3,4-Octadecanetriol, 2-amino-, (2S, 3S, 4R)-||554-62-1|
|28||α-D-glycopyranoside, methyl, monoether with triglycerol, dioctadecanoate||157175-98-9|
|29||Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-, ether with methyl β-D-glucopyranoside (4:1)||61849-72-7|
|31||Carbomer, sodium salt||73298-57-4|
|32||β-D-Glucan, (1-3)-, carboxymethyl ether, sodium salt||9050-93-5|
|33||Dextran, carboxymethyl ether, sodium salt||39422-83-8|
|34||DNA, sodium complexes||438545-06-3|
|35||Dodecanoic acid, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl ester, sodium salt||13557-75-0|
|36||L-Glutamic acid, N-(1-oxooctadecyl)-, monosodium salt||38517-23-6|
|38||Benzoic acid, 2-hydroxy-, tridecyl ester||19666-16-1|
|39||1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1,2,3-tris(2-octyldodecyl) ester||126121-35-5|
|40||1-Propanaminium, 2-(acetyloxy)-3-carboxy-N,N,N-trimethyl-, chloride, (2R)-||5080-50-2|
|42||Fats and Glyceridic oils, shea butter, unsaponifiable fraction||225234-14-0|
|43||Dodecanoic acid, dodecyl ester||13945-76-1|
|44||Waxes and waxy substances, orange roughy||91078-99-8|
|45||Sanguisorba officinalis, extract||84787-71-3|
|47||L-Glutamic acid, N-(1-oxododecyl)-, mixed (3β)-cholest-5-en-3-yl and docosyl and octyldodecyl esters||244023-78-7|
|48||Manganese, chloro[[2,2’-[1,2-ethanediylbis[(nitrilo-κN)methylidyne]]bis[6-methoxyphenolato-κO]](2-)]-, (SP-5-13)-||81065-76-1|
|49||Micrococcus luteus, lysate||158765-79-8|
|50||Amylopectin, 2-hydroxy-3-(trimethylammonio)propyl ether, polymer with 1,2,3-propanetriol, hexadecanoate||528855-60-9|
|52||Propanoic acid, 2,2-dimethyl-, 2-octyldodecyl ester||158567-66-9|
|53||3,5,8-Trioxa-4-phosphaundec-10-en-1-aminium, 4-hydroxy-N,N,N,10-tetramethyl-9-oxo-, inner salt, 4-oxide, polymer with butyl 2-methyl-2-propenoate||125275-25-4|
|54||Mulberry, Morus bombycis, extract||1174920-93-4|
|55||Benzoic acid, 2-[4-(diethylamino)-2-hydroxybenzoyl]-, hexyl ester||302776-68-7|
|56||Propanol, (tetradecyloxy)-, acetate||135326-54-4|
|58||Brazil nut, extract||160965-04-8|
|59||Potentilla recta, extract||90083-09-3|
|60||Aspalathus linearis, extract||776295-36-4|
|62||Poria cocos, extract||168456-53-9|
|63||Scutellaria baicalensis, extract||94279-99-9|
|64||Hexanoic acid, 2-ethyl-, C16-18-alkyl esters||90411-68-0|
Chemicals that will become conditions of introduction or use under AICIS
Chemicals with NICNAS conditions of use that will become conditions of introduction or use under AICIS
|Item||Chemical name||CAS no.|
|1||C.I. Pigment Yellow 34||1344-37-2|
|2||1-Propanol, 2,3-dibromo-, phosphate (3:1)||126-72-7|
|3||Hexanoic acid, 2-ethyl-, lead(2+) salt||301-08-6|
|4||Lead oxide (PbO2)||1309-60-0|
|5||Lead oxide (Pb3O4)||1314-41-6|
|6||Lead oxide (PbO)||1317-36-8|
|8||Octanoic acid, lead(2+) salt||7319-86-0|
|9||Sulfuric acid, lead(2+) salt (1:1)||7446-14-2|
|10||Chromic acid (H2CrO4), lead(2+) salt (1:1)||7758-97-6|
|11||Nitric acid, lead(2+) salt||10099-74-8|
|12||Molybdic acid (H2MoO4), lead(2+) salt (1:1)||10190-55-3|
|13||C.I. Pigment Red 104||12656-85-8|
|14||Lead chromate oxide (Pb2(CrO4)O)||18454-12-1|
|15||Naphthenic acids, lead salts||61790-14-5|
|16||1,2-benzenedicarboxylic acid, bis(2-propylheptyl) ester||53306-54-0|
|18||2-Propenoic acid, reaction products with acetic acid (ϒ-ω-perfluoro-C8-10-alkyl) thio derivs. Bu esters and polyethylenimine||1374418-39-9|
|19||Thioimidodicarbonic acid ((HO)C(O)NHC(S)(OH)), O,O’-dibutyl ester||39142-36-4|
|20||Carbamic acid, [(butylthio)thioxomethyl]-, butyl ester||1001320-38-2|
What will happen to my pending early listing application 1 July 2020?
What will happen to my pending application for a confidential listing at 1 July 2020?
If you have applied for listing on the confidential Inventory before 1 July 2020, but we haven’t made a decision by that date, we'll continue to process your application but the decision will be made under transitional arrangements.
We will continue to process your application and apply the same statutory criteria that balance commercial prejudice and public interest.
If we approve your pending application for confidential listing, your chemical will not be searchable on the AICIS public website and we won't publish any information about it.
We'll contact you with more details about your application.
Listing due date — what happens if there are multiple certificates for same chemical?
Introducers with later certificates will be consulted about listing. When a chemical is due for listing on the AICIS Inventory, we'll contact all affected parties.
Who we notify when a chemical is due for listing on the Inventory
- Each holder of an assessment certificate for the chemical
- Anyone covered by an extension to the certificate
- Each confidence holder
Like now, there will be an option to apply for the chemical to be listed confidentially on the AICIS Inventory.
We'll publish more guidance about this as we head towards the new scheme.
Confidential listing if you apply for a certificate under NICNAS but we issue it under AICIS
You can still apply for confidentiality when your chemical is due to be listed.Once you get the assessment certificate you'll have the option of early listing on the Inventory, otherwise the standard 5 year non-listing period applies.
We'll contact you before the chemical is due to be listed on the Inventory. At this point you'll have the option to apply online for the chemical to be confidentially listed on the Inventory. If we grant confidentiality, your chemical will not be searchable on our website and we won't publish any details about it.
Like now, anyone with a genuine intent to import or manufacture the chemical will be able to make a request via our Business Services site to search for confidentially listed chemicals on the Inventory.
I want my assessed chemical to be confidential but it's not due for listing until 1 July 2020
If you hold a NICNAS assessment certificate and your chemical will be listed on the Inventory under AICIS, you will be able to apply for your chemical details to be confidentially listed on the Inventory.
You can only apply after we contact you to let you know that your chemical is due to be listed on the Inventory. If we grant confidentiality, your chemical will not be searchable on our website and we won't publish any details about it.
Anyone with a genuine intent to import or manufacture the chemical can make a request via our Business Services site to search for confidentially listed chemicals on the Inventory.
Last update 5 March 2020